secondary obesity

(redirected from CNS disease)
Obesity due to endocrine or other systemic disease

secondary obesity

Obesity due to endocrine or other systemic disease. See Morbid obesity, Obesity.
Secondary obesity
Congenital Alström-Hallgren syndrome, Carpenter syndrome, Cohen syndrome, Lawrence-Moon-Biedl syndrome, Prader-Willi syndrome, Vasquez syndrome
CNS disease Defects of hypophyseal-hypothalamic axis, intracranial leukemia, and other lesions
Endocrinopathies Hypothyroidism, insulinoma, Cushing syndrome, polycystic ovary disease, pituitary dwarfism
References in periodicals archive ?
CNS disease treatment company Innovative California Biosciences International Inc (ICBII) said on Tuesday that it has filed an Orphan Drug Designation status application with the US Food and Drug Administration (FDA) for the use of ?
The data, along with other published preclinical data from animal models of CNS disease and injury, show that delivering healthy glial cells into the brain and spinal cord can alter the course of incurable CNS conditions.
The material will be used by Neuway for the conduct of GLP toxicity studies and initiation of clinical development in the treatment of Progressive Multifocal Leukoencephalopathy, a very severe neurodegenerative CNS disease.
13) Additional viruses that may be associated with CNS disease but are less frequently observed in immunocompetent adults include FIIV and arboviruses, such as West Nile, St.
Major organization : STATE BUDGETARY HEALTHCARE INSTITUTION MOSCOW REGION "PSYCHONEUROLOGICAL HOSPITAL FOR CHILDREN WITH CNS DISEASE WITH MENTAL DISORDERS"
Ampio, based in Greenwood Village, Colorado, develops drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction.
In conclusion, PML constitutes the most frequent JCV-associated CNS disease in our setting, but novel presentations were observed.
That's just one of several reasons why early diagnosis of neonatal herpes simplex virus (HSV) CNS disease can be so difficult.
Published case reports and case series of pediatric blastomycosis highlight the potential for pulmonary, bone, and CNS disease, as weil as neonatal disease and intrauterine transmission (6,15-20).
12) Lymphoblastic histology, stage IV disease, and B symptoms are also associated with increased risk of CNS disease.
On the other hand, the AMA says that Delaware's law requires physicians to report patients who are subject to losses of consciousness due to CNS disease.